These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7643458)
41. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774 [TBL] [Abstract][Full Text] [Related]
42. [1st use of lactitol in the treatment of porto-systemic encephalopathy]. Bircher J; Bührer M; Franz K; van Velthuijsen JA Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954 [TBL] [Abstract][Full Text] [Related]
43. [Hepatic encephalopathy and liver transplantation]. Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880 [TBL] [Abstract][Full Text] [Related]
44. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Cammà C; Fiorello F; Tinè F; Marchesini G; Fabbri A; Pagliaro L Dig Dis Sci; 1993 May; 38(5):916-22. PubMed ID: 8482191 [TBL] [Abstract][Full Text] [Related]
45. [Ameliorating effect of lactitol on experimental hepatic encephalopathy in Eck fistula dogs]. Watanabe M; Ozaki T; Mushiroi T; Ukai Y; Ueda F; Kimura K; Katoh M; Matsumoto A; Kotani E; Itoh S Nihon Yakurigaku Zasshi; 1995 May; 105(5):403-13. PubMed ID: 7628788 [TBL] [Abstract][Full Text] [Related]
46. Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora. Weber FL Dig Dis; 1996; 14 Suppl 1():53-63. PubMed ID: 8872452 [TBL] [Abstract][Full Text] [Related]
47. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use]. Fehér J; Prónai L Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363 [TBL] [Abstract][Full Text] [Related]
48. Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology. Finney M; Smullen J; Foster HA; Brokx S; Storey DM Eur J Nutr; 2007 Sep; 46(6):307-14. PubMed ID: 17623227 [TBL] [Abstract][Full Text] [Related]
49. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995 [TBL] [Abstract][Full Text] [Related]
50. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis. Blanc P; Daures JP; Rouillon JM; Peray P; Pierrugues R; Larrey D; Gremy F; Michel H Hepatology; 1992 Feb; 15(2):222-8. PubMed ID: 1531204 [TBL] [Abstract][Full Text] [Related]
51. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752 [TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349 [TBL] [Abstract][Full Text] [Related]
53. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients]. Grandi M; Sacchetti C; Pederzoli S; Celani MF Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974 [TBL] [Abstract][Full Text] [Related]
54. Effects of lactitol-oligosaccharides on the intestinal microflora in rats. Yanahira S; Morita M; Aoe S; Suguri T; Nakajima I; Deya E J Nutr Sci Vitaminol (Tokyo); 1995 Feb; 41(1):83-94. PubMed ID: 7616329 [TBL] [Abstract][Full Text] [Related]